Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share News

UK earnings, trading statements calendar - next 7 days

5th Nov 2024 14:48

Read More

IN BRIEF: AstraZeneca China President Leon Wang under investigation

30th Oct 2024 14:30

AstraZeneca PLC - Cambridge, England-based pharmaceutical company - Reports that AstraZeneca China President Leon Wang is cooperating with an ongoing investigation by Chinese authorities. Wang is also executive vice president of the International division. "Our China operations continue under the leadership of the current general manager of AstraZeneca China. If requested, AstraZeneca will fully cooperate with the investigation," the company says. Read More

AstraZeneca pleased as EU approves Fasenra for treatment of EGPA

28th Oct 2024 08:46

(Alliance News) - AstraZeneca PLC on Monday welcomed approval in the European Union of Fasenra for the treatment of eosinophilic granulomatosis with polyangiitis. Read More

LONDON BRIEFING: Lloyds notes motor finance case; Trainline ups guide

28th Oct 2024 07:50

(Alliance News) - London's FTSE 100 is called to open higher on Monday, after decent trade in Asia at the start of the week, while the yen sank on political uncertainty in Japan. Read More

AstraZeneca polyneuropathy treatment recommended for EU approval

21st Oct 2024 08:35

(Alliance News) - AstraZeneca PLC on Monday said its Wainzua treatment has been been recommended for EU approval to treat adult patients with polyneuropathy associated with hereditary transthyretin-mediated amyloidosis. Read More

LONDON BRIEFING: BHP dam trial begins in UK; Hollywood Bowl confident

21st Oct 2024 07:52

(Alliance News) - London's FTSE 100 is called to open largely flat on Monday, in a tentative start to the week, despite rate cuts in China. Read More

TOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows promising results

16th Oct 2024 09:52

(Alliance News) - Hutchmed China Ltd on Wednesday said that Tagrisso plus Orpathys showed a high clinically meaningful response rate in patients with a form of lung cancer. Read More

LONDON MARKET MIDDAY: Stocks go red as cautious sentiment prevails

14th Oct 2024 12:24

(Alliance News) - Stock prices in London were lower at midday on Monday, as investors wait for a number of inflationary prints later in the week. Read More

TOP NEWS: Enhertu by AstraZeneca, Daiichi wins new approval in China

14th Oct 2024 10:42

(Alliance News) - AstraZeneca PLC on Monday said that its antibody drug conjugate Enhertu won another approval in China. Read More

LONDON MARKET OPEN: Stocks defy China data to start green

14th Oct 2024 08:56

(Alliance News) - Stock prices in London opened just about higher on Monday morning, inching up despite disappointing data from China, and reports of new restrictions on the UK gambling sector. Read More

LONDON MARKET OPEN: FTSE 100 resilient but China equities slump

9th Oct 2024 08:47

(Alliance News) - London's FTSE 100 moved higher on Wednesday morning, shaking off nervy trade in China, where stimulus disappointment weighed on the mood. Read More

LONDON BROKER RATINGS: Goldman Sachs starts Barclays at 'buy'

8th Oct 2024 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

AstraZeneca enters agreement to strengthen cardiovascular pipeline

7th Oct 2024 10:20

(Alliance News) - AstraZeneca PLC on Monday entered into an exclusive license agreement with CSPC Pharmaceutical Group Ltd to advance the development of an early stage, novel small molecule lipoprotein disruptor for patients with dyslipidaemia. Read More

TOP NEWS: AstraZeneca hails Airsupra trial results to treat asthma

7th Oct 2024 08:52

(Alliance News) - AstraZeneca PLC on Monday said an independent data monitoring committee recommended an early trial stop for its medication Airsupra due to overwhelming efficacy at pre-planned analysis for the treatment of asthma. Read More

TOP NEWS: AstraZeneca's Calquence gets priority review in US

3rd Oct 2024 11:01

(Alliance News) - AstraZeneca PLC on Thursday said its cancer treatment Calquence obtained priority review by the US Food & Drug Administration for a form of lymphoma. Read More

LONDON BROKER RATINGS: Morgan Stanley cuts BAT; boohoo gets buy rating

3rd Oct 2024 09:39

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More

LONDON MARKET MIDDAY: Stocks go red but FTSE 100 up on oil exposure

2nd Oct 2024 12:31

(Alliance News) - Stock prices in London were predominantly lower at midday on Wednesday, though the FTSE 100 continued in the green, thanks to its exposure to the oil and defence sectors. Read More

TOP NEWS: AstraZeneca and Daiichi hail Enhertu priority review in US

1st Oct 2024 09:39

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Tuesday said their cancer drug Enhertu received a priority review by the Food & Drug Administration in the US for some forms of breast cancer. Read More

LONDON MARKET OPEN: FTSE 100 green but other stocks slip ahead of PMIs

1st Oct 2024 09:01

(Alliance News) - Stock prices in London opened a mixed bag in London on Tuesday, with the FTSE 100 in the green, but compatriot indices in the red, ahead of a slew of manufacturing PMIs later in the day. Read More

LONDON BRIEFING: Stocks open in green following UK shop price data

1st Oct 2024 08:05

(Alliance News) - Stocks opened higher in London on Tuesday morning, after data showed that UK shop prices have moved further into deflation. Read More

FTSE 100 Latest
Value8,809.74
Change53.53